MariMed Sees Significant Drop in Short Interest

Cannabis company's short interest declines by over 40% in March

Mar. 28, 2026 at 9:08pm

Got story updates? Submit your updates here. ›

MariMed Inc. (OTCMKTS:MRMD), a multi-state cannabis company, saw a significant decrease in short interest in March 2026. As of March 13th, the company's short interest totaled 14,026 shares, a 43.6% drop from the 24,883 shares reported on February 26th. This represents approximately 0.0% of the company's total shares outstanding.

Why it matters

The decline in short interest suggests that investor sentiment towards MariMed may be improving, as short sellers are reducing their bets against the company's stock. This could indicate growing confidence in the company's performance and future prospects within the cannabis industry.

The details

According to the report, one research analyst has rated MariMed's stock as a 'Moderate Buy', while two others have given it a 'Hold' rating. MariMed is a multi-state cannabis company focused on the development, ownership, and operation of regulated cannabis facilities for medical and adult-use markets. The company cultivates, processes, and dispenses cannabis through an integrated business model that includes cultivation, formulation, manufacturing, and retail operations.

  • As of March 13th, 2026, MariMed's short interest totaled 14,026 shares.
  • On February 26th, 2026, MariMed's short interest was 24,883 shares.

The players

MariMed Inc.

A multi-state cannabis company focused on the development, ownership, and operation of regulated cannabis facilities for medical and adult-use markets. The company cultivates, processes, and dispenses cannabis through an integrated business model.

Got photos? Submit your photos here. ›

The takeaway

The significant decline in short interest for MariMed's stock suggests that investors are becoming more optimistic about the company's prospects within the cannabis industry. This could indicate growing confidence in the company's performance and its ability to navigate the evolving regulatory landscape.